Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 3,785.00
+50.00 (1.34%)
Oct 2, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 229.85 billion as of October 2, 2026. Its market cap has decreased by -41.68% in one year.
Market Cap
229.85B
Enterprise Value
288.06B
Revenue
99.15B
Ranking
n/a
PE Ratio
23.98
Stock Price
3,785.00
ChartMarket Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 229.85B, a decrease of -49.08%. That is a compound annual growth rate of -12.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 232.93B | -24.75% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WON TECH | 429.24B |
| Sky Labs | 346.16B |
| Samyang Biopharm | 337.59B |
| Curexo | 336.27B |
| ToolGen | 310.78B |
| Value Added Technology | 260.25B |
| Vieworks | 233.16B |
| JETEMA, | 232.67B |